ZAP70 IN T CELL DEVELOPMENT
ZAP70 IN T CELL DEVELOPMENT
批准号:
6497656
负责人:
John Atkinson
金额:
$20.34万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-17 至 2003-01-31
中文摘要
描述(摘自《调查者摘要》):蛋白质酪氨酸
蛋白酪氨酸激酶(PTK)在T细胞的发育中起着不可或缺的作用。
许多细胞质PTK的突变或缺失会导致多种
免疫缺陷。一种这样的PTK是Zeta链相关的PTK,ZAP-70。
在人类和小鼠身上的研究证明了ZAP-70的核心重要性
在T细胞发育和T细胞发育中的作用。人类的缺席
ZAP-70与一种常染色体隐性形式的重症联合
免疫缺陷。这些患者没有CD8+外周T细胞,
有正常数量的无功能的CD4+T细胞。缺乏ZAP-70的小鼠
该基因缺乏CD4+和CD8+外周T细胞。此外,ZAP-70也是
对于T细胞的适当选择和发育是必需的。而当
这些初步研究证明了ZAP-70在
胸腺细胞的发育和TCR谱系的适当选择
ZAP-70介导这些差异巨大的生物的机制(S)
对此的回应仍不清楚。对ZAP-70在心脏疾病中的作用
胸腺细胞的发育将为免疫细胞中的PTKs提供一个范例
发展,并可能提供对发展的差异的洞察力
对CD4+和CD8+T细胞的需求。此外,这些研究可能会提供
药物治疗干预的额外机制信息
为T细胞淋巴瘤、免疫缺陷、自身免疫性疾病和
移植排斥反应。
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): Protein tyrosine
kinases (PTKs) play an integral role in the development of T cells.
Mutations or the absence of a number of cytoplasmic PTKs result a variety of
immunodeficiencies. One such PTK is the zeta-chain associated PTK, ZAP-70.
Studies in both humans and mice demonstrate the central importance of ZAP-70
in T cell development and T cell development function. Absence of human
ZAP-70 is associated with an autosomal recessive form of severe combined
immunodeficiency. These patients develop no CD8+ peripheral T cells and
have normal numbers of nonfunctional CD4+ T cells. Mice lacking the ZAP-70
gene lack both CD4+ and CD8+ peripheral T cells. Moreover, zap-70 is also
required for the appropriate selection and development of T cells. While
these initial studies demonstrate the central importance of ZAP-70 in
thymocyte development and appropriate selection of the TCR repertoire, the
mechanism(s) by which ZAP-70 can mediate these vastly diverse biological
responses remain unclear. An understanding of how ZAP-70 functions in
thymocyte development will provide a paradigm for PTKs in immune cell
development and may provide insights into differences in the developmental
requirements of CD4+ and CD8+ T cells. Moreover, these studies may provide
additional mechanistic information for therapeutic interventions in drug
design for T cell lymphomas, immunodeficiencies, autoimmune diseases, and
transplantation rejection.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1084/jem.194.4.507
发表时间:
2001-08-20
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Gong Q, Jin X, Akk AM, Foger N, White M, Gong G, Bubeck Wardenburg J, Chan AC]
通讯作者:
Chan AC
Scleroderma Renal Crisis as a Genetic Complementopathy
-
批准号:10159866
-
项目类别:
-
资助金额:$16.83万
-
财政年份:2020
-
负责人:John Atkinson
-
依托单位:
Defining the Complosome in Human Cells, Tissues and Disease States
-
批准号:10597611
-
项目类别:
-
资助金额:$39.37万
-
财政年份:2020
-
负责人:John Atkinson
-
依托单位:
Defining the Complosome in Human Cells, Tissues and Disease States
-
批准号:10375425
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2020
-
负责人:John Atkinson
-
依托单位:
Complement Activation Signatures in Systemic Lupus Erythematosus: Castle Study
-
批准号:9317177
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2017
-
负责人:John Atkinson
-
依托单位:
Protein Core
-
批准号:8915044
-
项目类别:
-
资助金额:$18.28万
-
财政年份:2015
-
负责人:John Atkinson
-
依托单位:
Protein Core
-
批准号:8379367
-
项目类别:
-
资助金额:$18.26万
-
财政年份:2012
-
负责人:John Atkinson
-
依托单位:
Flavivirus NS-1, complement and disease susceptibility
-
批准号:7672127
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2009
-
负责人:John Atkinson
-
依托单位:
Protein Core
-
批准号:7667780
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2008
-
负责人:John Atkinson
-
依托单位:
SMALLPOX VIRULENCE AND COMPLEMENT REGULATORY PROTEINS
-
批准号:7641538
-
项目类别:
-
资助金额:$38.97万
-
财政年份:2008
-
负责人:John Atkinson
-
依托单位:
Protein Core
-
批准号:7485262
-
项目类别:
-
资助金额:$16.56万
-
财政年份:2007
-
负责人:John Atkinson
-
依托单位:
Complement Signaling and Treg Cells
-
批准号:7150335
-
项目类别:
-
资助金额:$24.27万
-
财政年份:2006
-
负责人:John Atkinson
-
依托单位:
COMPLEMENT RECEPTOR ONE (CR1)--STRUCTURE/FUNCTION
-
批准号:6373665
-
项目类别:
-
资助金额:$25.42万
-
财政年份:1997
-
负责人:John Atkinson
-
依托单位:
COMPLEMENT RECEPTOR ONE (CR1)--STRUCTURE/FUNCTION
-
批准号:6170486
-
项目类别:
-
资助金额:$24.68万
-
财政年份:1997
-
负责人:John Atkinson
-
依托单位:
COMPLEMENT RECEPTOR ONE (CR1)--STRUCTURE/FUNCTION
-
批准号:2887506
-
项目类别:
-
资助金额:$23.96万
-
财政年份:1997
-
负责人:John Atkinson
-
依托单位:
Complement Receptor One (CRI): Structure/Function
-
批准号:6748539
-
项目类别:
-
资助金额:$30.6万
-
财政年份:1997
-
负责人:John Atkinson
-
依托单位:
C3, CR1, CRRY: INTERACTIONS, HOMEOSTASIS AND TRANSLATIONAL IMPLICATIONS
-
批准号:8038297
-
项目类别:
-
资助金额:$37.24万
-
财政年份:1997
-
负责人:John Atkinson
-
依托单位:
C3, CR1, CRRY: INTERACTIONS, HOMEOSTASIS AND TRANSLATIONAL IMPLICATIONS
-
批准号:7767653
-
项目类别:
-
资助金额:$37.62万
-
财政年份:1997
-
负责人:John Atkinson
-
依托单位:
Complement Receptor One (CRI): Structure/Function
-
批准号:6903463
-
项目类别:
-
资助金额:$30.6万
-
财政年份:1997
-
负责人:John Atkinson
-
依托单位:
C3, CR1, CRRY: INTERACTIONS, HOMEOSTASIS AND TRANSLATIONAL IMPLICATIONS
-
批准号:7652861
-
项目类别:
-
资助金额:$38.0万
-
财政年份:1997
-
负责人:John Atkinson
-
依托单位:
C3, CR1, CRRY: INTERACTIONS, HOMEOSTASIS AND TRANSLATIONAL IMPLICATIONS
-
批准号:8215707
-
项目类别:
-
资助金额:$37.24万
-
财政年份:1997
-
负责人:John Atkinson
-
依托单位:
海外基金